^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TmEGFR/IL13Rα2 01 CAR-T

    i
    Other names: TmEGFR/IL13Rα2 01 CAR-T, IL13Rα2 CAR-T, Anti-EGFR/IL-13R alpha 2 CAR T cell therapy, Anti-Epidermal growth factor receptor/ Interleukin 13 Receptor subunit alpha 2 CAR-T therapy, CART-EGFR-IL13Ra2
    Associations
    News
    Trials
    Company:
    Gilead, University of Pennsylvania
    Drug class:
    EGFR-targeted CAR-T immunotherapy, IL-13-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials